Montelukast Tablet
Product Images NDC 33342-102

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 33342-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Montelukast 30s

Montelukast Sodium Tablets 10 mg oral tablets label by Macleods Pharmaceuticals Limited. The label indicates packaging of 30 tablets intended for adults 15 years and older. It provides storage instructions and manufacturer information for Macleods Pharma USA, Inc., Plainsboro, NJ, and Macleods Pharmaceuticals Ltd., India. NDC 33342-102.*

FDA Label Image

Montelukast 500s

Label for Montelukast Sodium Tablets 10 mg by Macleods Pharmaceuticals Limited. The label includes dosage strength (10 mg), packaging size of 500 tablets, storage instructions (20° to 25°C), and manufacturing information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label also advises dispensing the patient information leaflet with the product.*

FDA Label Image

Montelukast 90s

Montelukast Sodium Tablets 10 mg oral tablets, packaged in a bottle label with a quantity of 90 tablets. The label is from Macleods Pharmaceuticals Limited, with the NDC 33342-102-10, indicating it is for adults 15 years and older. It includes storage instructions and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd, India.*

FDA Label Image

Montelukast-fig-1 (Montelukast Fig 1)

A line graph showing mean percent change from baseline over weeks in treatment (0 to 15 weeks) comparing placebo and Montelukast Sodium. Montelukast Sodium shows a higher mean percent change with a peak around 12 weeks followed by a washout period, while placebo remains lower and more stable over the same period.*

FDA Label Image

Montelukast-structural (Montelukast Structural)

Chemical structure of Montelukast showing its molecular framework, including chlorine, sulfur, sodium, and hydroxyl groups as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.